BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/29/2014 7:34:00 PM | Browse: 1143 | Download: 785
Publication Name World Journal of Gastroenterology
Manuscript ID 6556
Country South Korea
Received
2013-10-24 13:31
Peer-Review Started
2013-10-24 22:53
To Make the First Decision
2014-02-28 19:10
Return for Revision
2014-03-07 17:50
Revised
2014-04-03 01:40
Second Decision
2014-06-05 10:37
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-05 11:06
Articles in Press
2014-06-05 11:22
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-10-16 10:41
Publish the Manuscript Online
2014-10-29 19:34
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are?
Manuscript Source Invited Manuscript
All Author List Kyung-Hyun Kim and Kwan-Kyu Park
Funding Agency and Grant Number
Corresponding Author Kwan-Kyu Park, MD, PhD, Department of Pathology, College of Medicine, Catholic University of Daegu, 3056-6 Daemyung 4-Dong, Nam-Gu, Daegu 705-718, South Korea. kkpark@cu.ac.kr
Key Words Liver cirrhosis; gene therapy; Oligodeoxynucleotides; Antisense; small interfering RNA; micro RNA; Decoy
Core Tip Recent advances in understanding the mechanisms underlying liver fibrogenesis, including regulation of inflammatory cytokine signaling, the dynamic process of hepatic stellate cell activation and extracellular matrix degradation. The only option for patients suffering from severe and late-stage cirrhosis is liver transplantation; however, it is limited by the number of available donor organs. Therefore, development of new therapeutic strategies for liver fibrosis and cirrhosis are needed. This review focuses on the recent advances relating to the therapeutic application of liver fibrogenesis through the modulation of gene expression.
Publish Date 2014-10-29 19:34
Citation Kim KH, Park KK. Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are? World J Gastroenterol 2014; 20(40): 14696-14705
URL http://www.wjgnet.com/1007-9327/full/v20/i40/14696.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i40.14696
Full Article (PDF) WJG-20-14696.pdf
Full Article (Word) WJG-20-14696.doc
Manuscript File 6556-Review.docx
Answering Reviewers 6556-Answering reviewers.pdf
Copyright License Agreement 6556-Copyright assignment.pdf
Peer-review Report 6556-Peer reivew(s).pdf
Scientific Misconduct Check 6556-CrossCheck.jpg
Scientific Editor Work List 6556-Scientific editor work list.pdf